Literature DB >> 14971044

Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3.

Elizabeth J Pishko1, Girish S Kirimanjeswara, Mylisa R Pilione, Lakshmi Gopinathan, Mary J Kennett, Eric T Harvill.   

Abstract

To assess the contribution of complement to respiratory immunity in the context of a natural bacterial infection, we used mice genetically deficient in complement components and the murine pathogen Bordetella bronchiseptica. Complement component C3 was not required for the control of bacterial infection or for the generation of infection-induced protective immunity. However, C3-deficient (C3(-/-)) mice were severely defective, compared to wild type, in vaccine-induced protective immunity. Adoptively transferred immune serum from convalescent wild-type or C3(-/-) animals rapidly cleared B. bronchiseptica from the lungs of wild-type mice but did not affect its growth in C3(-/-) mice, indicating that the defect is not in the generation of protective immunity, but in its function. Immune serum was effective in C5-deficient mice but had little effect in the lungs of mice lacking either Fcgamma receptors (FcgammaR) or CR3, suggesting bacterial clearance is not via direct complement-mediated lysis. Together, these data indicate that complement is required for antibody-mediated clearance of Bordetella and suggest the mechanism involves C3 opsonization of bacteria for phagocytosis that is both CR3- and FcgammaR-dependent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971044     DOI: 10.1002/eji.200324234

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.

Authors:  Mylisa R Pilione; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

3.  The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Authors:  Mylisa R Pilione; Eric T Harvill
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Constraint-based network model of pathogen-immune system interactions.

Authors:  Juilee Thakar; Assieh Saadatpour-Moghaddam; Eric T Harvill; Réka Albert
Journal:  J R Soc Interface       Date:  2008-10-24       Impact factor: 4.118

5.  Snapshot of spatio-temporal cytokine responses to single and co-infections with helminths and bacteria.

Authors:  Ashutosh K Pathak; Michael C Biarnes; Lisa Murphy; Isabella M Cattadori
Journal:  Results Immunol       Date:  2011-11-04

Review 6.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Contribution of Bordetella bronchiseptica filamentous hemagglutinin and pertactin to respiratory disease in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

9.  The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving; Karen B Register; Marcus E Kehrli; Sarah M Shore
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

10.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.